Filter
607
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
52
New Publications
198
Language
Document type
No document type
335
Studies & Reports
104
Guidelines
88
Manuals
34
Strategic & Response Plan
26
Fact sheets
8
Situation Updates
5
Training Material
4
Resource Platforms
2
Brochures
1
Countries / Regions
Kenya
36
Ethiopia
31
India
25
Uganda
24
South Africa
20
Ghana
17
Tanzania
17
Liberia
16
Rwanda
16
Nigeria
15
Zambia
15
Malawi
13
Nepal
11
Sierra Leone
10
Zimbabwe
10
Western and Central Europe
10
Bangladesh
9
Namibia
8
Ukraine
8
Myanmar / Burma
8
Lesotho
7
Global
7
Eastern Europe
6
Philippines
5
Indonesia
5
Eswatini/ Swaziland
5
Botswana
5
Syria
4
Cambodia
4
Benin
3
Albania
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
Cameroon
2
Haiti
2
Pakistan
2
Jordan
2
Thailand
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Laos
2
USA
1
Somalia
1
Afghanistan
1
Germany
1
Chad
1
Mozambique
1
Papua New Guinea
1
Sudan
1
North Macedonia
1
East and Southern Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Fiji
1
Timor Leste/ East Timor
1
Moldova
1
Australia
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
325
Clinical Guidelines
33
Pharmacy & Technologies
19
Key Resources
17
Public Health
9
Women & Child Health
8
Capacity Building
3
Toolboxes
Pharmacy
88
AMR
81
COVID-19
30
TB
23
Rapid Response
22
HIV
19
Mental Health
17
Global Health Education
9
Ebola
6
Conflict
6
Planetary Health
6
Health Financing Toolbox
5
NCDs
4
Specific Hazards
3
Caregiver
3
NTDs
3
Polio
2
Refugee
2
Natural Hazards
1
Zika
1
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But
...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedical engineering resources. This publication is int
...
Towards the Peoples Health Assembly Book -5
Guidance on Implending Publi-Private Mix Approaches
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c
...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec
...
These guidelines are applicable to all biomedical, social and behavioural science research for health conducted in India involving human participants, their biological material and data.
The purpose of such research should be: i. directed towards enhancing knowledge about the human condition while
...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Свод методических рекомендаций состоит из нескольких тематически связанных и удобных для пользователя модулей для решения широкого спектра задач и приоритетных
...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t
...
